The development of the ReSPCT guidelines involved a diverse range of perspectives, ensuring that the checklist is applicable across different cultural and clinical contexts. The 89 experts involved in the Delphi study included psychiatrists, psychologists, pharmacologists, and indigenous practitioners, reflecting the multifaceted nature of psychedelic use. The 17-country involvement ensures that the guidelines are not just a Western-centric model but a global standard that can be utilized in diverse healthcare systems.
The items in the checklist cover three primary domains: the "set" (the participant’s internal state, expectations, and psychological preparation), the "setting" (the physical environment, the presence of music, and the aesthetic qualities of the space), and the "provider" (the characteristics, training, and behavior of the therapists or guides present during the session). By systematically reporting these factors, researchers can begin to identify which specific elements of the "setting" contribute most to positive clinical outcomes.
For example, if multiple trials across the world use the ReSPCT guidelines and all find that a specific type of musical intervention or a specific duration of "integration therapy" following the dose leads to better long-term recovery from depression, the medical community can move toward a more optimized, evidence-based protocol for delivery.
The research team is not stopping at the publication of the guidelines. They are already moving toward the implementation phase to ensure these standards are adopted by the global scientific community. A three-day workshop is scheduled for October, funded by McGill University’s Healthy Brains, Healthy Lives (HBHL) initiative. This event will gather leading experts in psychedelics, neuroscience, and clinical trial design to discuss the practicalities of integrating the ReSPCT guidelines into both ongoing research and future clinical practice.
The workshop aims to bridge the gap between theoretical guidelines and the reality of the lab and clinic. It will address how to train researchers to use the checklist effectively and how to encourage journals and regulatory bodies to require these standards as a prerequisite for publication and drug filing.
As the "psychedelic renaissance" continues to accelerate, the move toward standardization marks a maturing of the field. By acknowledging that the mind and the environment are just as important as the molecule, the researchers at McGill, Imperial, and Exeter are providing the necessary infrastructure to turn experimental treatments into validated medical therapies. The ReSPCT guidelines represent a significant step toward a future where mental health treatments are not just about chemical balance, but about the holistic experience of the patient.
